Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81703326, 81973177, 81773580)
Science and Technology Department of Henan Province (182102310123)
Postdoctoral Research Foundation of China (2018M630840, 2019T120641)
Guangdong Key Laboratory for Translational Cancer Research of Chinese Medicine (2018B030322011)
the open fund of state key laboratory of Pharmaceutical Biotechnology, Nan-jing University, China (KF-GN-201902)
- License Information
-
More Information
Article History
Received: 11 September 2019
Accepted: 23 October 2019
First Online: 4 December 2019
Ethics approval and consent to participate
: Not applicable.
: We declared that this manuscript is original, has not been published before, and is not currently being considered for publication elsewhere.
: The authors declare that they have no competing interests.
